RUNX1 and acute myeloid leukemia: (32) showed that EVI1 plays an important role in the key properties of AML leukemic stem cells, and all-trans retinoic acid (ATRA) enhances the effects of EVI1 on AML stemness, thus, raising the possibility of using RAR antagonists in the therapy of EVI1high AML.